Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

National Anti-Vivisection Society and International Foundation for Ethical Research Announce Renewal of Research Grants for Promising Young Investigators
  • USA - English


News provided by

National Anti-Vivisection Society

Oct 28, 2014, 12:00 ET

Share this article

Share toX

Share this article

Share toX

Chicago, IL (PRWEB) October 28, 2014 -- The National Anti-Vivisection Society (NAVS) and the International Foundation for Ethical Research (IFER) are pleased to announce that three recipients of IFER Graduate Fellowships have been selected to have their grants renewed as part of the 2014-2015 grant cycle. By funding early career researchers with an interest in developing innovative alternatives to animal experiments, NAVS and IFER hope to seed the scientific field with talented individuals prepared to integrate scientific discovery with ethics and respect for animals.

Recipients of IFER Graduate Fellowships, selected by IFER’s Scientific Advisory Board, have the potential to positively change the course of science by working to promote the advancement of humane methodologies that can spare animal suffering.

The IFER Graduate Fellowship recipients whose grants have been renewed for 2014-2015 are:

Georgina Harris, a Ph.D. student working with Dr. Lena Smirnova and Dr. Thomas Hartung at the Center for Alternatives to Animal Testing at Johns Hopkins University Bloomberg School of Public Health, will be receiving her second year of support from IFER for her project, “Identification of pathways of developmental neurotoxicity (DNT) of environmental chemicals by omics technologies.” Georgina’s project aims to establish methods for assessing developmental neurotoxicity in vitro using human cells. As current strategies to evaluate DNT rely heavily on animal models which lack human-relevance, raise ethical concerns and are expensive, Georgina’s work has the potential to revolutionize DNT studies while reducing the use of animals in this area. Her work has caught the attention of researchers worldwide, as she was recently invited to present her research at the 9th World Congress on Alternatives and Animal Use in the Life Sciences in Prague, Czech Republic.

Nicole Sparks, a Ph.D. student under the mentorship of Dr. Nicole l. zur Nieden at the University of California, Riverside, is in her third year of funding from IFER for her project “In Vitro Prediction of Skeletal Teratogenicity of Environmental Chemicals.” Nicole continues to make impressive progress in her efforts to develop a method which uses human stem cells to accurately predict and identify compounds that can cause skeletal abnormalities during development. As existing tests of this nature rely on animals and have low predictability for human effects, the need for a human-relevant in vitro skeletal embryotoxicity screen has never been greater.

David Tran, a Ph.D. student working under Dr. Steven George at the University of California, Irvine, has received a second year of IFER support for his project, “Development of a patient-specific high-throughput cardiac drug-screening platform.” David has been generating an in vitro model using human induced pluripotent stem cells as a source for human cardiomyocytes to examine the pharmacokinetics and toxicity of drugs. Over the past year, his model has undergone several changes to improve its functionality and enable it to better characterize the effects of drugs on heart function. Development of such a model is critical, as a significant portion of rejected drugs fail in humans as a result of cardiotoxic side effects not evident in animal models.

IFER Graduate Fellowships are awarded annually in amounts up to $15,000 to early career scientists who are developing alternatives to the use of animals in product testing, biomedical research and education. Fellowships are renewable for up to three years. More information on the IFER Graduate Fellowship Program can be found at http://www.ifer.org/fellowships.php.

ABOUT THE NATIONAL ANTI-VIVISECTION SOCIETY
Founded in 1929, the National Anti-Vivisection Society (NAVS) promotes greater compassion, respect and justice for animals through educational and advocacy programs based on respected ethical, scientific and legal theory. NAVS works to increase public awareness about animal experimentation, to promote positive solutions that advance science, to support the development of alternatives to the use of animals, and to effect changes that will help end the unnecessary suffering of animals. For more information, visit http://www.navs.org.

ABOUT THE INTERNATIONAL FOUNDATION FOR ETHICAL RESEARCH
Founded in 1985, the International Foundation for Ethical Research (IFER) supports the development, validation and implementation of innovative scientific methodologies that advance science and replace the use of animals in research, testing and education. IFER is funded primarily by a grant from the National Anti-Vivisection Society.

Garett Auriemma, National Anti-Vivisection Society, http://www.navs.org, +1 (312) 427-6065 Ext: 225, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.